ERBB2 and adenocarcinoma: MDA-MB231 human triple-negative breast cancer cells (adenocarcinoma), HCC1954 Her2-positive breast cancer cells (ductal carcinoma), and PC14 lung adenocarcinoma cells were evaluated.